Haselmeier GmbH

About Haselmeier GmbH

Haselmeier, a part of medmix, has been established in the healthcare marketplace for over 100 years. Starting as a family-owned business with approximately 240 employees, Haselmeier has been pioneering the development of injection pens for subcutaneous application since the 1960s. We continue to drive innovation in self-injection pens from design and manufacturing to packaging and delivery. We have developed solutions in scalable volumes for numerous pharmaceutical partners, always following state-of-the-art engineering practices – and we aim to envolve even further. 

We empower safe self-administration of liquid drugs through the patient-centric development and manufacture of intelligent injection devices that improve the efficiency and efficacy of therapy.

Our innovative product platforms and related service portfolios assist you every step of the way – leading to an advanced combination of drug and device that is as time-saving and economical for your company as it is safe and convenient in therapy. We support you at every stage – from technolo...

Certifications
  • DE
  • 2021
    On CPhI since
  • 2
    Certificates
  • 100 - 249
    Employees
Engineering
Manufacturer/Innovator
Contact info

Products from Haselmeier GmbH

  • D-Flex™ Injection Pen

    Product D-Flex™ Injection Pen

    The D-Flex™ is a fixed-dose pen system for multiple injections based on 3 ml cartridges. Users can easily adjust the dose to the titration scheme of a  given treatment simply by replacing one component. With between 1 and 10 clearly separated, fixed doses in just one pen, the D-Flex™ bridges the gap between fixed and variable-dose pens. This innovative product platform also paves the way for connected commercial devices.

    The products shown on this website are under development and some of them may not yet have been approved for sale under applicable medical devices regulation. The content provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical devices manufacturer and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical devices regulation nor is it directed at patients or intended to replace professional medical advice.

  • D-Flex™ Ecosystem

    Product D-Flex™ Ecosystem

    The D-Flex™ Ecosystem consists of the D-Flex™ injection pen, a connected cap, a mobile app and the Haselmeier™ data platform. The connected cap collects data at the point of care, securely transferring it to the mobile app and from there to any platform. In this way D-Flex™ Ecosystem enables real-time monitoring and advanced analytics in clinical trials.

    D-Flex™ Pen - Easy adjustable: The D-Flex™ is a fixed-dose pen for multiple injections based on a 3 ml cartridge. Clearly separated, fixed doses on just one pen, giving you flexibility during your dose-finding phase. This innovative product platform can be customized by changing only one component of the pen, reducing the time for R&D. Patients benefit from significantly reduced choice of doses.
    D-Flex™ Connected CapSeamless data collection: The connected solution with a digital cap operating with patented, Bluetooth (BLE)-enabled dose-sensing technology, the digital cap measures the dispensed dose, time and temperature, enabling seamless data collection at the point of care. D-Flex™ Connect is based on a proven technology that can be adapted to your needs.

    Health AppData capture atthe point of care: Patients can replace the standard cap with the new connected cap enabling automatic data capture at the point of care. Collected data is immediately transferred to the Haselmeier™ data platform via an app. This customizable app can remind patients manage their appointments with physicians and provide help or training.

    Health Platform- A data-transfer Ecosystem: The Haselmeier™ data platform provides data storage within the cloud, in compliance with all regulatory and safety requirements. The platform can transfer data to any existing clinical trial infrastructure (eCRF), minimizing additional IT resources. Advanced analytics, dashboards and CE certification are further customizable options.



    The products shown on this website are under development and some of them may not yet have been approved for sale under applicable medical devices regulation. The content provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical devices manufacturer and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical devices regulation nor is it directed at patients or intended to replace professional medical advice.
  • Our Product Platforms

    Product Our Product Platforms

    Our innovative product platforms and related service portfolios assist you every step of the way – leading to an advanced combination of drug and device that is as time-saving and economical for your company as it is safe and convenient in therapy. We support you at every stage – from technology to therapy. 

    The D-Flex™ technical platform is a disposable pen platform for the usage with 3ml cartridges. Its design covers a freely selectable regular or irregular dose regimen. The platform can be set to deliver just one single dose or a number of fixed doses. An adaption to a number of pre-selected doses is possible too. The pen system is equipped with a proprietary mechanism to prevent unintended dose selection. D-Flex™ is the ideal and flexible platform designed for easy customisation of preset dose volumes. This platform accompanies and supports you from dose escalation studies to commercial product and adds potential to reduce „Time to Market“ and „CAPEX“. The dynamic D-Flex™ pen platform is available in a high quality plastic version.

    The Axis-D™ pen platform is a disposable, variable dose injection device system designed for the use with a 3 ml cartridge. The elegant and compact Axis-D™ pen platform is available as a high quality plastic version with a large range of ergonomic options for an attractive and colorful design.

    The Pentek™ pen platform is a multi-dose, fixed dose injection device platform designed for use with a standard 3 ml cartridge. The Pentek™ pen platform features Haselmeier‘s hidden needle design which hides the needle from the patient before and during the injection. Pressing the clip on the pen causes the needle to automatically enter the subcutaneous tissue, followed by delivery of the fixed volume of the solution. 

    The i-pen product platform is the basis for a compact, patient-centered solution for easy subcutaneous self-application. Designed based on extensive research and patient testing, the i-pen technology can help improve safety, convenience and quality of life. The i-pen product platform features an attractive design and an extensive range of customization and different color examples.

    The i-pen² product platform is the basis for a reusable injection pen for use in diabetes treatment and other areas of care. Specifically created to provide a high-quality pen at an affordable cost, this innovative pen product platform is available in standard Haselmeier design or can be customized to your specific requirements.
    The products shown on this website are under development and some of them may not yet have been approved for sale under applicable medical devices regulation. The content provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical devices manufacturer and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical devices regulation nor is it directed at patients or intended to replace professional medical advice.











Haselmeier GmbH Resources